27 results
F-6 POS
EX-99
LIANY
LianBio
12 Mar 24
Automatic registration for ADRs (post-effective amendment, foreign)
8:30am
of public infrastructure (including communication or utility failure), failure of common carriers, nuclear, cyber or biochemical incident, any pandemic … or utility failure), failure of common carriers, nuclear, cyber or biochemical incident, any pandemic, epidemic or other prevalent disease or illness
8-K
EX-99.2
LIANY
LianBio
10 Nov 22
LianBio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:16pm
Rapidly growing IBD incident population in China NX-13 (NLRX1 agonist) for the treatment of IBD In Ph1a safety study, NX-13 was shown to be well
8-K
EX-99.2
fwvj 8syxzrge9
11 Aug 22
LianBio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-99.2
jycp6xf30sxg l5wpe
12 May 22
LianBio Reports First Quarter 2022 Financial Results and Provides Corporate Update
9:15am
8-K
EX-99.1
8dx2tqxbbm2jk
2 Mar 22
Regulation FD Disclosure
4:42pm
10-Q
2a5bkvh5 ui8dxfedy
9 Dec 21
Quarterly report
5:24pm
424B4
l0bb7l e48w759nd5o
2 Nov 21
Prospectus supplement with pricing info
4:02pm
F-6/A
EX-99
ezvnri go3cx01v51fse
26 Oct 21
Registration for ADRs (foreign) (amended)
4:34pm
S-1/A
5pszj5vfiv5 ooj9s
8 Oct 21
IPO registration (amended)
5:09pm
S-1/A
EX-4.1
my42cg
8 Oct 21
IPO registration (amended)
5:09pm
F-6
EX-99
27lj5n39tarp 7f5st
8 Oct 21
Registration for ADRs (foreign)
5:00pm